Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Textiles Press Releases.
Press releases published on June 3, 2025

NIO Inc. Reports Unaudited First Quarter 2025 Financial Results
SHANGHAI, June 03, 2025 (GLOBE NEWSWIRE) -- NIO Inc. (NYSE: NIO; HKEX: 9866; SGX: NIO) (“NIO” or the “Company”), a pioneer and a leading company in the global smart electric vehicle market, today announced its unaudited financial results for the first …

Bravo | HGTV | Food Network | Discovery | FX | Magnolia Network | ID: Fan-Favourite Shows Lead Powerhouse Specialty Portfolio from Rogers Sports & Media
– Bravo remains the exclusive TV home to iconic hit reality titles including new shows The Real Housewives of Rhode Island and The Valley: Persian Style (working title), along with the biggest unscripted series: The Real Housewives of Beverly Hills, Below …

Market Shakeup Triggers Flight to Diversification—Global Investors Rally Behind BCC Mining
Phoenix, Arizona, June 03, 2025 (GLOBE NEWSWIRE) -- As major cryptocurrencies like BTC, SOL, XRP, and GOGE experience heightened price swings, some large investors—often referred to as "whales" and "giant whales"—are beginning to explore alternative …

Emerging Markets Report: Shedding Some Light
An Emerging Markets Sponsored Commentary ORLANDO, Fla., June 03, 2025 (GLOBE NEWSWIRE) -- While there are no crystal balls in modern financial markets there are the words of those who know more, who share from the inside out the state of affairs inside a …

Gilat Signs a $40 Million Contract for Virtualized SkyEdge IV Platform
PETAH TIKVA, Israel, June 03, 2025 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, announced today that it has received a $40 million contract for …

Vanqua Bio to Present at Upcoming Scientific Conferences
CHICAGO, June 03, 2025 (GLOBE NEWSWIRE) -- Vanqua Bio, a clinical-stage biopharmaceutical company, announced that the company will present interim Phase 1 data for its lead clinical program, VQ-101, at two upcoming scientific conferences – the GBA1 Meeting …

Fury Announces 2025 Exploration Plans at Committee Bay
TORONTO, June 03, 2025 (GLOBE NEWSWIRE) -- Fury Gold Mines Limited (TSX and NYSE American: FURY) (“Fury” or the “Company”) is pleased to provide an update on exploration plans for the Committee Bay project, located in the eastern Kitikmeot region of …

Bitget Launches Second Year of Anti-Scam Month Campaign to Fight Growing Cyber Fraud
VICTORIA, Seychelles, June 03, 2025 (GLOBE NEWSWIRE) -- Bitget, the leading cryptocurrency exchange and Web3 company, has officially launched the second year of its Anti-Scam Month, a global initiative run to spread crypto security awareness. In a world …

VEON and Engro Corporation Complete Pioneering Infrastructure Partnership in Pakistan
Islamabad and Dubai, June 3, 2025: VEON Ltd. (Nasdaq: VEON), a global digital operator (“VEON” or “the Company”), announces that it has successfully closed the partnership for the pooling and management of telecommunications infrastructure assets in …

Akero Therapeutics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, today …

Guardian Capital LP Launches New GuardBonds™ Funds
TORONTO, June 03, 2025 (GLOBE NEWSWIRE) -- Guardian Capital LP ( “Guardian Capital”) is excited to announce the launch of GuardBonds™ 2028 Investment Grade Bond Fund (Cboe: GBFE) and GuardBonds™ 2029 Investment Grade Bond Fund (Cboe: GBFF) (the “New …

Greenbacker delivers first quarter results
Company announces year-over-year increases in IPP revenue, power production, and generation capacity in its operating fleet, as well as construction milestones on largest solar project in New York Key Takeaways Against a backdrop of trade policy driven …

Monopar Therapeutics Announces Inclusion in the Russell 3000® and Russell 2000® Indexes
WILMETTE, Ill., June 03, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical‐stage biopharmaceutical company focused on developing innovative treatments for patients with unmet medical needs, today …

FactSet Announces CEO Succession Plan
Sanoke Viswanathan Appointed Chief Executive Officer Effective Early September 2025 Phil Snow to Retire After Accomplished 30-Year Career with FactSet, Including 10 Years as CEO NORWALK, Conn., June 03, 2025 (GLOBE NEWSWIRE) -- FactSet (NYSE: FDS | NASDAQ: …

BioStem Technologies Provides Update on the Company’s Form 10 Submission and SEC Review Process
POMPANO BEACH, Fla., June 03, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (“BioStem” or the “Company”) (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for …

Halcones Precious Metals Provides Update on Polaris Gold Project, Antofagasta Region Chile
TORONTO, June 03, 2025 (GLOBE NEWSWIRE) -- Halcones Precious Metals Corp. (TSX – V: HPM) (the “Company” or “Halcones”) is pleased to provide an update on progress at its Polaris Gold Project (the “Project” or “Polaris”). Halcones’ geologists continue field …

Beam Therapeutics Announces U.S. FDA Orphan Drug Designation Granted to BEAM-101 for the Treatment of Sickle Cell Disease
CAMBRIDGE, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the United States (U.S.) Food and Drug Administration (FDA) …

Xtract One Announces Updates on One Gateway Launch
TORONTO, June 03, 2025 (GLOBE NEWSWIRE) -- Xtract One Technologies Inc. (TSX: XTRA) (OTCQX: XTRAF) (FRA: 0PL) (“Xtract One” or the “Company”) a leading technology-driven threat detection and security solution company that prioritizes the patron access …

Traws Pharma Announces Publication of Compelling Efficacy data in RDEB SCC Patients Treated with Legacy Oncology Drug Rigosertib
NEWTOWN, Pa., June 03, 2025 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (NASDAQ: TRAW) (“Traws Pharma”, “Traws” or “the Company”), a clinical-stage biopharmaceutical company developing novel therapies to target critical threats to human health from respiratory …

BeyondSpring Presents Efficacy/Safety Data from a Phase 2 Study of Pembrolizumab plus Plinabulin/Docetaxel in Metastatic NSCLC after Progressing on First-Line Immune Checkpoint Inhibitors at 2025 ASCO Annual Meeting
Median PFS at 6.8 months, Disease Control Rate of 77.3%, 15 months OS% at 78% in Metastatic NSCLC Patients after Progression on PD-1/L1 Therapies FLORHAM PARK, N.J., June 03, 2025 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the …